The impact and indications for Oncotype DX on adjuvant treatment recommendations when third ‐party funding is unavailable

Asia-Pacific Journal of Clinical Oncology, EarlyView.

Source: Asia-Pacific Journal of Clinical Oncology - October 1, 2018 Category: Cancer & Oncology Authors: L. Chin ‐Lenn, R. H. Boer, E. Segelov, G. M. Marx, T. M. Hughes, N. J. McCarthy, S. C. White, S. S. Foo, J. J. Rutovitz, S. Della‐Fiorentina, R. Jennens, Y. C. Antill, D. Tsoi, M. F. Cronk, J. M. Lombard, B. E. Kiely, J. H. Chirgwin, Source Type: research